NHS vs private weight-loss medication

Three routes to GLP-1 weight-loss medication in the UK in 2026. One is NHS-funded and tightly rationed. One is a middle-ground NHS service you may be able to access. One is fully private. We describe each honestly so you can pick the one that genuinely suits your situation.

Route 1: NHS weight-management services (Tier 3 and Tier 4)

The NHS commissions weight management services in four tiers. Tier 3 is specialist multidisciplinary community weight management. Tier 4 is bariatric surgery and intensive medical management.

For GLP-1 prescribing (Wegovy specifically) the current (April 2026) NHS offer is:

Wegovy is available through Tier 3 specialist weight management services, typically accessed via GP referral. Mounjaro is now also available through Tier 3 services after NICE approval in December 2024, but is being rolled out slowly.

The eligibility criteria are strict: BMI of 35 or higher with at least one weight-related comorbidity, or BMI of 30-34.9 for specific high-risk patient groups (typically those from South Asian, Black, or Middle Eastern backgrounds where metabolic risk is higher at lower BMI).

Treatment duration is capped at two years on the NHS.

The catch is access. Most regions have waiting lists of 12-24 months for Tier 3. Many Integrated Care Boards have paused or deprioritised Mounjaro prescribing while assessing cost implications. If you qualify and can wait, it is genuinely worth pursuing.

Best choice if: you qualify clinically, you can wait, your region is actively commissioning Tier 3 services, and you are prepared for a structured group-programme model of care rather than one-to-one.

Route 2: Oviva NHS service

Oviva runs an NHS-contracted programme in parts of England that provides Wegovy and recently Mounjaro on an NHS-funded basis with an app-based behavioural programme. It is legitimate, well-run, and genuinely free to eligible patients.

Eligibility is similar to Tier 3: BMI 30 or higher with weight-related comorbidity, referred by your GP, in a commissioned region.

Wait times for Oviva are shorter than regional Tier 3 services (typically 2-4 months). The programme is digital-first with app check-ins and video sessions rather than in-person appointments.

Best choice if: you qualify, your region is commissioned, and you prefer a structured app-based programme with lifestyle support included.

Route 3: fully private (LoveMyLife and others)

You pay and you get the medication quickly, usually the same day. Private GLP-1 care in the UK market splits into three tiers:

• Volume digital clinics. £150 to £340 per month depending on medication and dose. Online prescribing with video review, medication supplied through a third-party pharmacy. Best for patients who already know what they want, who have a straightforward clinical picture, and who want the lowest monthly cost.

• Clinician-led private clinics including LoveMyLife. £249 for the initial assessment with the first month of medication included, then £245 per month including medication from our own pharmacy. GP-led assessment, in-person option at Westfield London, doctor-dispensed at visit.

• Premium consultant-led clinics. £500 to £1,500 for the initial assessment, £300 to £500 per month for ongoing care including medication. Appropriate for complex patients with multiple endocrine or metabolic conditions; rarely necessary for standard weight management.

A private route is the right answer if you want speed, a continuous clinician relationship, and integration with the rest of your health. It is the wrong answer when an NHS route is available, you qualify, and you can wait.

What year one actually costs

| Route | Year 1 cost | |---|---| | NHS Tier 3 (if you qualify and get in) | Free | | Oviva NHS (if commissioned in your region) | Free | | LoveMyLife private | ~£2,945 (online) / ~£3,190 (in-person) | | Volume digital clinics | £1,800 to £4,000 depending on dose and provider | | Premium consultant-led clinics | £4,000 to £6,000+ |

LoveMyLife year one at around £2,945 includes the initial assessment, twelve months of GLP-1 medication dose-adjusted as needed, monthly clinical reviews, unlimited messaging, quarterly body-composition review, twice-yearly comprehensive metabolic bloods, and same-day dispensing from our own pharmacy.

When private is the wrong answer

We will tell you if we think an NHS Tier 3 service or Oviva would suit you better. Situations where we will point you toward the NHS route:

• You clearly meet NHS eligibility (BMI 35+, significant comorbidity) and live in a region with a functioning Tier 3 service.

• You are on a low income where £2,945 in the first year is a genuine financial stretch.

• You need the structured behavioural support that Tier 3 or Oviva provides, which we supplement rather than replicate.

• You are happy to wait and the urgency of starting is modest.

We make no money from telling you this. A clinician-led weight-management service only works if the clinical advice is honest about when the NHS route is a better fit.

The honest summary

Private is the right answer if you want speed, genuine clinical review, continuity, and the integration with the rest of your health (bloods, CV risk, menopause, ADHD, whatever else is going on). NHS is the right answer if you qualify, you can wait, and a group-programme model suits you. Most patients we see chose private because the waiting list in their area was two years or the Tier 3 service was not accepting new referrals.

Ready to start?

If this article has made you think medication might help, the next step is a short consultation with one of our weight-management doctors.

Begin your consultation at this link. Online in 30 minutes, or in person at Westfield London.